Literature DB >> 12093948

Health care services utilization in children with obstructive sleep apnea syndrome.

Haim Reuveni1, Tzahit Simon, Asher Tal, Asher Elhayany, Ariel Tarasiuk.   

Abstract

OBJECTIVE: Little is known about the effects of obstructive sleep apnea syndrome (OSAS) on utilization of health care services in children. The present study compares medical service utilization by children with OSAS with that of healthy children.
METHODS: A cross-sectional study of 287 consecutively recruited children (1-18 years) with OSAS and no concomitant diseases and a control group matched by age, gender, and geographic location was conducted at the Clalit Health Care Services clinic in the southern region of Israel. Children in the study group underwent nocturnal polysomnography (PSG) studies. The control group (N = 1149) was randomly selected from the Clalit Health Care Services database. PSG was performed for the OSAS patients. Indices of health care utilization 1 year before the PSG study were analyzed.
RESULTS: A 226% increase in health care utilization was noted among children with OSAS. Children up to 5 years of age consumed more health care resources than children over 5 years. Children with OSAS consumed more health care services than the control group at all ages. The leading components of this high cost are utilization of more hospital days, drugs, and visits to the emergency department. The severity of the OSAS correlates directly to total annual costs and independently to age (beta = 0.19).
CONCLUSIONS: Children with OSAS are heavy consumers of health care services 1 year before any specific evaluation and treatment for apnea. Early diagnosis and intervention may be cost-effective.

Entities:  

Mesh:

Year:  2002        PMID: 12093948     DOI: 10.1542/peds.110.1.68

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.

Authors:  Teresa M Ward; Dean W Beebe; Maida Lynn Chen; Carol A Landis; Sarah Ringold; Ken Pike; Carol A Wallace
Journal:  J Rheumatol       Date:  2017-01-15       Impact factor: 4.666

Review 2.  Sleep . 8: paediatric obstructive sleep apnoea.

Authors:  G M Nixon; R T Brouillette
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

Review 3.  Evaluation and Management of Children with Obstructive Sleep Apnea Syndrome.

Authors:  Anna C Bitners; Raanan Arens
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

4.  CON: Specific pediatric accreditation is not critical for integrated pediatric and adult sleep medicine programs.

Authors:  David Gozal
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

5.  Treatment of childhood obstructive sleep apnea.

Authors:  Ameet S Daftary; Suresh Kotagal
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

6.  Effect of sleep on upper airway dynamics in obese adolescents with obstructive sleep apnea syndrome.

Authors:  Anna C Bitners; Sanghun Sin; Sabhyata Agrawal; Seonjoo Lee; Jayaram K Udupa; Yubing Tong; David M Wootton; Kok Ren Choy; Mark E Wagshul; Raanan Arens
Journal:  Sleep       Date:  2020-10-13       Impact factor: 5.849

7.  Treatment outcomes of adenotonsillectomy for children with obstructive sleep apnea: a prospective longitudinal study.

Authors:  Yu-Shu Huang; Christian Guilleminault; Li-Ang Lee; Cheng-Hui Lin; Fan-Ming Hwang
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

8.  Primary healthcare costs associated with sleep problems up to age 7 years: Australian population-based study.

Authors:  J Quach; L Gold; H Hiscock; F K Mensah; N Lucas; J M Nicholson; M Wake
Journal:  BMJ Open       Date:  2013-05-31       Impact factor: 2.692

9.  Sleep medicine in Saudi Arabia: Current problems and future challenges.

Authors:  Ahmed S Bahammam
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

10.  Obstructive sleep apnea in children.

Authors:  Timothy F Hoban
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.